Related references
Note: Only part of the references are listed.I know what you told me, but this is what I think: Perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate
Erin Linnenbringer et al.
GENETICS IN MEDICINE (2010)
Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
Chung-Pu Wu et al.
Current Molecular Pharmacology (2010)
siRNA delivery systems for cancer treatment
Yu-Kyoung Oh et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
In vivo and in vitro effects of SREBP-1 on diabetic renal tubular lipid accumulation and RNAi-mediated gene silencing study
Hao Jun et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2009)
Concepts in In Vivo siRNA Delivery for Cancer Therapy
Christopher S. Gondi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
Myriam Aouadi et al.
NATURE (2009)
Transport proteins of the ABC family and multidrug resistance of tumor cells
A. A. Stavrovskaya et al.
BIOCHEMISTRY-MOSCOW (2008)
Development of inhibitors of ATP-binding cassette drug transporters - present status and challenges
Suneet Shukla et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels
N. Widmer et al.
LEUKEMIA (2007)
Human multidrug resistance ABCB and ABCG transporters:: Participation in a chemoimmunity defense system
Balazs Sarkadi et al.
PHYSIOLOGICAL REVIEWS (2006)
Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs
V Stierlé et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis
RM Schiffelers et al.
ARTHRITIS AND RHEUMATISM (2005)
Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model
GS Ralph et al.
NATURE MEDICINE (2005)
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal
Cheol-Hee Choi
CANCER CELL INTERNATIONAL (2005)
Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis
XC Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Expression of the MDR1 and MRP genes in patients with lymphoma with primary bone marrow involvement
AN Zenkov et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2004)
Silencing of MDR 1 gene in cancer cells by siRNA
EB Logashenko et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2004)
Transcriptional regulation of ABC drug transporters
KW Scotto
ONCOGENE (2003)
Functional siRNAs and rniRNAs exhibit strand bias
A Khvorova et al.
CELL (2003)
Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi)
C Nieth et al.
FEBS LETTERS (2003)
Senescence apoptosis and therapy - cutting the lifelines of cancer
CA Schmitt
NATURE REVIEWS CANCER (2003)
Small interfering RNA targeting Bcl-2 sensitizes malignant melanoma
V Wacheck et al.
OLIGONUCLEOTIDES (2003)
Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake
Hideo Makimura et al.
BMC NEUROSCIENCE (2002)
MDR1 genotype-related pharmacokinetics and pharmacodynamics
T Sakaeda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2002)
Both natural and designed micro RNAs technique can inhibit the expression of cognate mRNAs when expressed in human cells
Y Zeng et al.
MOLECULAR CELL (2002)
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
CA Schmitt et al.
CELL (2002)
Apoptosis: A link between cancer genetics and chemotherapy
RW Johnstone et al.
CELL (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
SM Elbashir et al.
NATURE (2001)
Apoptosis is critical for drug response in vivo
CA Schmitt et al.
DRUG RESISTANCE UPDATES (2001)
Metabolism and pharmacokinetics of oxazaphosphorines
AV Boddy et al.
CLINICAL PHARMACOKINETICS (2000)
Genetic analysis of chemoresistance in primary murine lymphomas
CA Schmitt et al.
NATURE MEDICINE (2000)
DNA damage responses and chemosensitivity in the E mu-myc mouse lymphoma model
CA Schmitt et al.
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY (2000)